Editorial for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective.

Aguado, J.M.; Manuel, O.

doi:10.1016/j.cmi.2018.04.029

Editorial for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective.

Details

Request a copy

Serval ID

serval:BIB_ECD0BCBB110C

Type

Article: article from journal or magazin.

Collection

Publications

Institution

UNIL/CHUV

Title

Editorial for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective.

Journal

Clinical microbiology and infection

Author(s)

Aguado J.M., Manuel O.

ISSN

1469-0691 (Electronic)

ISSN-L

1198-743X

Publication state

Published

Issued date

06/2018

Peer-reviewed

Oui

Volume

24 Suppl 2

Pages

S1

Language

english

Notes

Publication types: Consensus Development Conference ; Editorial
Publication Status: ppublish

Keywords

Biological Therapy/adverse effects, Biological Therapy/methods, Communicable Diseases/therapy, Consensus, Humans, Immunocompromised Host, Molecular Targeted Therapy/adverse effects, Molecular Targeted Therapy/methods

OAI-PMH

oai:serval.unil.ch:BIB_ECD0BCBB110C

DOI

10.1016/j.cmi.2018.04.029

Pubmed

29803289

Web of science

000454246100001

Open Access

Yes

Create date

31/07/2019 6:48